1.
Garcia Arieta A, Simon C, Tam A, Mendes Lima Santos G, Freitas Fernandes EA, Rodríguez Martínez Z, Rodrigues C, Park SA, Kim J, Kim K, Kuribayashi R, Myoenzono A, Shimojo K, Walther C, Roost MS, Hung W-Y, Hsu L- feng, Crane C, Braddy AC, van Oudtshoorn J, Gutierrez Triana DA, Guzmán Aurela E, Jones B, Potthast H, Abalos I. A Survey of the Regulatory Requirements for the Waiver of In Vivo Bioequivalence Studies of Generic Products in Certain Dosage Forms by Participating Regulators and Organisations of the International Pharmaceutical Regulators Programme. J Pharm Pharm Sci [Internet]. 2021 Mar. 15 [cited 2022 Oct. 4];24:113-26. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31491